FDA product code JND: Nadp Reduction, 6-Phosphogluconate Dehydrogenase
JND is the FDA product code for nadp reduction, 6-phosphogluconate dehydrogenase. It is a Class I device, regulated under 21 CFR 862.1565 and reviewed by the Clinical Chemistry panel. Devices under JND reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Nadp Reduction, 6-Phosphogluconate Dehydrogenase |
| Device class | Class I |
| Regulation | 21 CFR 862.1565 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) exempt |
Recalls for JND devices
FDA recall records list no recalls for product code JND.
Frequently asked questions
What is FDA product code JND?
JND is the FDA product code for nadp reduction, 6-phosphogluconate dehydrogenase. It is a Class I device, regulated under 21 CFR 862.1565 and reviewed by the Clinical Chemistry panel.
What device class is JND?
Class I, regulation 21 CFR 862.1565. Typical premarket route: 510(k) exempt.
Next steps
- Run an FDA pathway report with predicate devices for product code JND
- Run a recall and safety report across every JND manufacturer
- Watch product code JND for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times